The TRUVADAPREP brand, founded in 2011 (United States), from 32 sister brands and 17477 competing brands. TRUVADAPREP is owned by Gilead Sciences, listed on the stock exchange of New York TRUVADAPREP is part of the Drug Manufacturers activity sector.
Investment simulator :
Portfolio valuation
Gilead Sciences
(TRUVADAPREP)
over 5 years*
USD 70.79